The UK Cystic
Fibrosis Gene Therapy Consortium (UK CFGTC)
The UK Cystic Fibrosis Gene
Therapy Consortium (UK CFGTC) is the unified research programme of the
three leading gene therapy groups in the UK. It was established in 2001
on the initiative of the Cystic Fibrosis Trust. The three member
research groups are headed by Prof. David Porteous at the University of
Edinburgh, Dr Deborah Gill and Dr Steve Hyde at the University of Oxford
and Prof. Eric Alton at Imperial College in London.
Click on the
links below to find out more.
/